Cambridge Investment Research Advisors »

Nephros shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Nephros (NEPH) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Nephros

Tip: Access up to 7 years of quarterly data

All positions including Nephros held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nephros by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $337k 69k 4.87

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Alphabet Inc Cap Stk Cl A (GOOGL)
Alphabet Inc Cap Stk Cl C (GOOG)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Cambridge Investment Research Advisors

Top funds holding Nephros

Wexford Capital
Vanguard Group
Bard Associates
Renaissance Technologies
Geode Capital Management
Cambridge Investment Research Advisors
HighTower Advisors
Mesirow Financial Investment Management International Equity
Essex Investment Management
William Blair $ Company
Navellier & Associates
De Lisle Partners
Quadrature Capital
Marshall Wace
XTX Topco

View all funds holding Nephros